Inventor · disambiguated record
Michael R. Mckeown
Also filed as: MCKEOWN MICHAEL R · MCKEOWN MICHAEL ROBERT
12 granted patents·5 pending applications·52 citations·filing 2013–2023
89Inventor score
Top patents by PatentIndex Score
17 records- 0191US9695172B2Diazepane derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Granted Jul 4, 2017·13 cites·74 claims
- 0290US9868994B2Methods of stratifying patients for treatment with retinoic acid receptor-α agonistsSYROS PHARMACEUTICALS INC·Filed 2017·Granted Jan 16, 2018·6 cites·22 claims
- 0388US9975896B2Inhibitors of transcription factors and uses thereofDANA FARBER CANCER INST INC·Filed 2014·Granted May 22, 2018·17 cites·33 claims
- 0486US10697025B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2018·Granted Jun 30, 2020·3 cites·27 claims
- 0584US10793571B2Uses of diazepane derivativesDANA FARBER CANCER INST INC·Filed 2015·Granted Oct 6, 2020·2 cites·20 claims
- 0684US10240210B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2017·Granted Mar 26, 2019·2 cites·27 claims
- 0781US9845508B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2016·Granted Dec 19, 2017·4 cites·7 claims
- 0880US11053552B2Methods of stratifying patients for treatment with retinoic acid receptor-α agonistsSYROS PHARMACEUTICALS INC·Filed 2019·Granted Jul 6, 2021·1 cites·22 claims
- 0980US10167518B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2017·Granted Jan 1, 2019·3 cites·7 claims
- 1074US2023042181A1Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 1173US9567301B2Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitorsWHITEHEAD INST BIOMEDICAL RES·Filed 2013·Granted Feb 14, 2017·1 cites·10 claims
- 1269US2021285059A1Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1367US11447831B2Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2020·Granted Sep 20, 2022·0 cites·27 claims
- 1466US11446309B2Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitorsDANA FARBER CANCER INST INC·Filed 2014·Granted Sep 20, 2022·0 cites·6 claims
- 1561US2024102106A1Methods of stratifying patients for treatment with retinoic acid receptor-alpha agonistsSYROS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1657US2021100813A1Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitorsDANA FARBER CANCER INST INC·Filed 2020·Application pending·0 cites
- 1734US2016347750A1Dihydropteridinone derivatives and uses thereofDANA FARBER CANCER INST INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Michael R. Mckeown files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →